Grandfield & Dodd, LLC Abb Vie Inc. Transaction History

Grandfield & Dodd, LLC

$1.58 Billion
Q3 2024

A detailed history of Grandfield & Dodd, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Grandfield & Dodd, LLC holds 5,532 shares of ABBV stock, worth $995,760. This represents 0.07% of its overall portfolio holdings.

Number of Shares

5,532

Previous 5,832 5.14%

Holding current value

$995,760

Previous $1 Million 9.2%

% of portfolio

0.07%

Previous 0.07%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$163.84 - $199.33 $49,152 - $59,799	-300 Reduced 5.14%	5,532 $1.09 Million
Q2 2024 Aug 09, 2024	SELL	$154.79 - $180.76 $2,167 - $2,530	-14 Reduced 0.24%	5,832 $1 Million
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $7,831 - $8,922	-49 Reduced 0.83%	5,846 $1.06 Million
Q3 2023 Oct 25, 2023	SELL	$133.59 - $154.65 $2,271 - $2,629	-17 Reduced 0.29%	5,895 $878,000
Q4 2022 Jan 20, 2023	SELL	$138.31 - $165.87 $414 - $497	-3 Reduced 0.05%	5,912 $0
Q1 2022 Apr 19, 2022	BUY	$131.98 - $163.75 $107,959 - $133,947	818 Added 16.05%	5,915 $960,000
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $52,210 - $66,061	-486 Reduced 8.7%	5,097 $690,000
Q3 2021 Oct 28, 2021	BUY	$106.4 - $120.78 $31,920 - $36,234	300 Added 5.68%	5,583 $600,000
Q2 2021 Jul 28, 2021	SELL	$105.21 - $117.21 $23,040 - $25,668	-219 Reduced 3.98%	5,283 $600,000
Q4 2020 Jan 29, 2021	SELL	$80.49 - $108.67 $4,829 - $6,520	-60 Reduced 1.08%	5,502 $590,000
Q2 2020 Jul 24, 2020	BUY	$73.37 - $98.18 $20,176 - $26,999	275 Added 5.2%	5,562 $550,000
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $22,639 - $34,324	351 Added 7.11%	5,287 $403,000
Q4 2019 Feb 07, 2020	SELL	$72.13 - $90.25 $27,048 - $33,843	-375 Reduced 7.06%	4,936 $437,000
Q3 2019 Oct 30, 2019	BUY	$62.98 - $75.72 $22,043 - $26,502	350 Added 7.06%	5,311 $402,000
Q2 2019 Jul 29, 2019	SELL	$65.7 - $83.98 $26,542 - $33,927	-404 Reduced 7.53%	4,961 $361,000
Q1 2019 Apr 26, 2019	SELL	$77.14 - $90.79 $33,093 - $38,948	-429 Reduced 7.4%	5,365 $432,000
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $90,850 - $112,043	-1,167 Reduced 16.76%	5,794 $534,000
Q3 2018 Nov 02, 2018	SELL	$88.91 - $98.84 $97,178 - $108,032	-1,093 Reduced 13.57%	6,961 $658,000
Q2 2018 Jul 27, 2018	SELL	$89.78 - $106.23 $105,311 - $124,607	-1,173 Reduced 12.71%	8,054 $746,000
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $311,269 - $416,819	-3,383 Reduced 26.83%	9,227 $873,000
Q4 2017 Feb 06, 2018	SELL	$89.56 - $98.21 $25,703 - $28,186	-287 Reduced 2.23%	12,610 $1.22 Million
Q3 2017 Nov 03, 2017	BUY	$69.85 - $89.22 $900,855 - $1.15 Million	12,897	12,897 $1.15 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandfield & Dodd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandfield & Dodd, LLC with notifications on news.

Account

Grandfield & Dodd, LLC Abb Vie Inc. Transaction History